Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05060016
Title A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Amgen

lung small cell carcinoma


AMG 757

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | BEL | AUT

No variant requirements are available.